Asset Details
Do you wish to reserve the book?
Cyclin-dependent protein kinases and cell cycle regulation in biology and disease
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Cyclin-dependent protein kinases and cell cycle regulation in biology and disease
Do you wish to request the book?
Cyclin-dependent protein kinases and cell cycle regulation in biology and disease
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Cyclin-dependent protein kinases and cell cycle regulation in biology and disease
2025
Overview
Cyclin Dependent Kinases (CDKs) are closely connected to the regulation of cell cycle progression, having been first identified as the kinases able to drive cell division. In reality, the human genome contains 20 different CDKs, which can be divided in at least three different sub-family with different functions, mechanisms of regulation, expression patterns and subcellular localization. Most of these kinases play fundamental roles the normal physiology of eucaryotic cells; therefore, their deregulation is associated with the onset and/or progression of multiple human disease including but not limited to neoplastic and neurodegenerative conditions. Here, we describe the functions of CDKs, categorized into the three main functional groups in which they are classified, highlighting the most relevant pathways that drive their expression and functions. We then discuss the potential roles and deregulation of CDKs in human pathologies, with a particular focus on cancer, the human disease in which CDKs have been most extensively studied and explored as therapeutic targets. Finally, we discuss how CDKs inhibitors have become standard therapies in selected human cancers and propose novel ways of investigation to export their targeting from cancer to other relevant chronic diseases. We hope that the effort we made in collecting all available information on both the prominent and lesser-known CDK family members will help in identify and develop novel areas of research to improve the lives of patients affected by debilitating chronic diseases.
Publisher
Nature Publishing Group UK,Nature Publishing Group
Subject
/ 692/4019
/ Cancer
/ Cyclin-Dependent Kinases - antagonists & inhibitors
/ Cyclin-Dependent Kinases - genetics
/ Cyclin-Dependent Kinases - metabolism
/ Disease
/ Humans
/ Kinases
/ Medicine
/ Neurodegenerative Diseases - enzymology
/ Neurodegenerative Diseases - genetics
/ Neurodegenerative Diseases - pathology
/ Oncology
/ Review
